Nanotechnology Approaches for Targeting Inflamed White Adipose Tissue: Implications for Insulin Resistance and Metabolic Syndrome

Serunjogi Ruth

Department of Clinical Pharmacy Kampala International University Uganda

Email: ruth.serunjogi@studwc.kiu.ac.ug

                                                                  ABSTRACT
Nanotechnology has emerged as a transformative approach to targeting metabolic disorders, particularly insulin resistance (IR) and metabolic syndrome (MetS), by addressing the underlying chronic inflammation in white adipose tissue (WAT). In obesity, WAT undergoes hypertrophy and dysregulation, leading to an infiltration of immune cells such as macrophages, which secrete pro-inflammatory cytokines, thereby exacerbating IR and contributing to the development of MetS. Traditional therapies, including insulin sensitizers, face limitations due to systemic side effects and suboptimal targeting of inflamed adipose tissue. Nanotechnology, with its ability to deliver therapeutic agents precisely to WAT, offers a solution to these challenges. This review explores the role of nanomaterials, including nanoparticles (NPs), nanostructured lipid carriers (NLCs), and nanosensors, in targeting inflamed adipocytes. Nanoparticles can be designed to encapsulate anti-inflammatory agents, modulate immune responses, and restore insulin sensitivity in adipose tissue. We provide an in-depth overview of various nanotechnology-based strategies for targeting WAT inflammation, including the development of functionalized nanocarriers that improve drug delivery specificity and minimize adverse effects. Furthermore, we examine the potential for clinical translation of these approaches and address the challenges, such as biocompatibility, targeting efficiency, and scalability. Ultimately, nanotechnology holds promise in providing more effective, personalized treatments for individuals suffering from IR and MetS, addressing the root causes of these disorders at the cellular level.

Keywords: Nanotechnology; White adipose tissue; Insulin resistance; Metabolic syndrome; Nanoparticles.

CITE AS: Serunjogi Ruth (2026). Nanotechnology Approaches for Targeting  Inflamed White Adipose Tissue: Implications for Insulin Resistance and Metabolic Syndrome. NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES, 7(2):72-77. https://doi.org/10.59298/NIJSES/2026/72.7277